Unknown NA INTERVENTIONAL 2-arm NCT03831269

Pityriasis Lichenoides Chronica, Role of Streptococcal Infection and Azithromycin

Role of Streptococcal Infection in the Etiopathogenesis of Pityriasis Lichenoides Chronica and the Therapeutic Efficacy of Azithromycin; a Randomized Controlled Trial

Sponsor: Cairo University

Conditions Pityriasis Lichenoides

Interventions Azithromycin nbUVB

Updated 5 times since 2019 Last updated: Feb 3, 2019 Started: Feb 28, 2019 Primary completion: Jun 30, 2020 Completion: Aug 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03831269, this NA trial focuses on Pityriasis Lichenoides and remains ongoing. Sponsored by Cairo University, it has been updated 5 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Oct 2021 — Jul 2024 [monthly]

Unknown Status NA

Status: Not Yet Recruiting → Unknown Status
Jan 2021 — Oct 2021 [monthly]

Not Yet Recruiting NA
Mar 2019 — Jan 2021 [monthly]

Not Yet Recruiting NA

First recorded

Feb 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cairo University

Data source: Cairo University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cairo, Egypt